These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 93589)

  • 1. Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
    Abramsky O; Brenner T
    Isr J Med Sci; 1979 Nov; 15(11):943-5. PubMed ID: 93589
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T; Beyth Y; Abramsky O
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3635-9. PubMed ID: 6158053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor.
    Abramsky O; Brenner T; Lisak RP; Zeidman A; Beyth Y
    Lancet; 1979 Dec 22-29; 2(8156-8157):1333-5. PubMed ID: 92675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation.
    Brenner T; Abramsky O
    Immunol Lett; 1981 Aug; 3(3):163-7. PubMed ID: 6169635
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myasthenia gravis and pregnancy. Review of the literature and considerations on the immunoprotective effect of alpha-fetoprotein through the observation of a clinical case].
    Gliaschera M; Biver P; Brunori E; Romani L; Tarani A; de Luca Brunori I
    Ann Ostet Ginecol Med Perinat; 1989; 110(1):20-7. PubMed ID: 2474264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytophilic antibodies in experimental autoimmune myasthenia gravis.
    Martinez RD; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1977 Jan; 118(1):17-20. PubMed ID: 830746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis and acetylcholine receptor].
    Abramsky O; Aharonov A; Tarrab-Hazdai R; Fuchs S
    Harefuah; 1975 Dec; 89(12):553-6. PubMed ID: 815144
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM; Richman DP
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of alpha-fetoprotein on the in vitro and in vivo immune response to acetylcholine receptor.
    Brenner T; Abramsky O; Lisak RP
    Ann N Y Acad Sci; 1981; 377():208-21. PubMed ID: 6176166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl].
    Denizot M; Fulpius BW; Cox JN; Ferrier PE
    Helv Paediatr Acta; 1979 Sep; 34(4):375-80. PubMed ID: 521303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes in myasthenia gravis.
    Barkas T; Boyle RS; Behan PO
    J Clin Lab Immunol; 1981 Jan; 5(1):27-30. PubMed ID: 7218325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine.
    Abramsky O; Tarrab-Hazdai R; Aharonov A; Fuchs S
    J Immunol; 1976 Jul; 117(1):225-8. PubMed ID: 932425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of alpha-fetoprotein in autoimmune diseases.
    Abramsky O; Brenner T
    Ann N Y Acad Sci; 1983; 417():108-16. PubMed ID: 6200026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.